Ketamine for Acute Migraine in the Emergency Department
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
This research study will be a prospective, randomized, double-blind, placebo-controlled
trial. Because ketamine has yet to be directly studied as treatment for acute migraine
headache in the emergency department, the research team is initially interested if ketamine
can reduce pain scores in headache patients and reduce the incidence of recurrence while
exhibiting an adequate safety profile. By using a placebo-controlled study design, the
research team can adequately investigate the effectiveness of the medication in a subgroup
previously not well studied.
Phase:
N/A
Details
Lead Sponsor:
Carilion Clinic
Collaborator:
Virginia Polytechnic Institute and State University